loading
전일 마감가:
$74.23
열려 있는:
$74.24
하루 거래량:
776.36K
Relative Volume:
0.70
시가총액:
$3.44B
수익:
-
순이익/손실:
$-38.99M
주가수익비율:
-24.45
EPS:
-2.9966
순현금흐름:
$-24.94M
1주 성능:
+4.69%
1개월 성능:
+46.37%
6개월 성능:
+33.39%
1년 성능:
+96.20%
1일 변동 폭
Value
$72.78
$74.27
1주일 범위
Value
$68.30
$74.50
52주 변동 폭
Value
$36.93
$74.50

Soleno Therapeutics Inc Stock (SLNO) Company Profile

Name
명칭
Soleno Therapeutics Inc
Name
전화
650-213-8444
Name
주소
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Name
직원
92
Name
트위터
Name
다음 수익 날짜
2024-11-05
Name
최신 SEC 제출 서류
Name
SLNO's Discussions on Twitter

SLNO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SLNO
Soleno Therapeutics Inc
73.26 3.44B 0 -38.99M -24.94M -2.9966
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-05 재개 Stifel Buy
2024-12-02 재확인 Robert W. Baird Outperform
2024-12-02 재확인 Stifel Buy
2024-09-03 개시 H.C. Wainwright Buy
2024-05-10 개시 Robert W. Baird Outperform
2024-02-05 개시 Piper Sandler Overweight
2024-01-23 개시 Stifel Buy
2023-11-21 재개 Guggenheim Buy
2020-09-29 개시 Guggenheim Buy
2020-01-10 개시 Craig Hallum Buy
2019-12-23 개시 Oppenheimer Outperform
2018-02-13 재확인 Maxim Group Buy
모두보기

Soleno Therapeutics Inc 주식(SLNO)의 최신 뉴스

pulisher
Apr 24, 2025

Piper Sandler raises Soleno Therapeutics stock target to $145 By Investing.com - Investing.com Nigeria

Apr 24, 2025
pulisher
Apr 24, 2025

Soleno Therapeutics (SLNO) Price Target Boosted to $145 by Piper Sandler | SLNO Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 23, 2025

Capnia Inc stock soars to 52-week high, hits $74.11 By Investing.com - Investing.com India

Apr 23, 2025
pulisher
Apr 23, 2025

Capnia Inc stock soars to 52-week high, hits $74.11 - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

Soleno Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 7, 2025, at 4:30 PM ET - The Manila Times

Apr 23, 2025
pulisher
Apr 23, 2025

Soleno Therapeutics to Report First Quarter 2025 Financial - GlobeNewswire

Apr 23, 2025
pulisher
Apr 23, 2025

Soleno Therapeutics Launches First-Ever Earnings Call: Key Details for Q1 2025 Financial Results - Stock Titan

Apr 23, 2025
pulisher
Apr 19, 2025

How To Trade (SLNO) - news.stocktradersdaily.com

Apr 19, 2025
pulisher
Apr 18, 2025

Soleno Therapeutics appoints CBIZ CPAs as new auditor By Investing.com - Investing.com Nigeria

Apr 18, 2025
pulisher
Apr 18, 2025

Soleno Therapeutics appoints CBIZ CPAs as new auditor - Investing.com Australia

Apr 18, 2025
pulisher
Apr 18, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Franklin Resources Inc. Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World

Apr 17, 2025
pulisher
Apr 14, 2025

Soleno launches Vykat xr for hyperphagia in Prader-Willi syndrome (SLNO:NASDAQ) - Seeking Alpha

Apr 14, 2025
pulisher
Apr 14, 2025

Soleno Therapeutics launches FDA-approved PWS treatment By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved - MSN

Apr 14, 2025
pulisher
Apr 14, 2025

Soleno Therapeutics launches FDA-approved PWS treatment - Investing.com

Apr 14, 2025
pulisher
Apr 14, 2025

Soleno Therapeutics Announces VYKAT(TM) XR Launch - The Manila Times

Apr 14, 2025
pulisher
Apr 14, 2025

Breakthrough PWS Treatment VYKAT XR Now Available: First-Ever FDA Approval for Rare Disease - Stock Titan

Apr 14, 2025
pulisher
Apr 14, 2025

SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug - MSN

Apr 14, 2025
pulisher
Apr 09, 2025

KLP Kapitalforvaltning AS Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

Soleno Therapeutics (SLNO) Gains FDA Approval for Prader-Willi T - GuruFocus

Apr 08, 2025
pulisher
Apr 05, 2025

SLNO Quantitative Stock Analysis - Nasdaq

Apr 05, 2025
pulisher
Apr 03, 2025

Capnia Inc stock soars to 52-week high, hits $74 mark - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Soleno therapeutics SVP sells $265,156 in stock By Investing.com - Investing.com India

Apr 03, 2025
pulisher
Apr 02, 2025

Soleno therapeutics SVP sells $265,156 in stock - Investing.com

Apr 02, 2025
pulisher
Apr 01, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Bhatnagar Anish Sells 699,095 Shares - MarketBeat

Apr 01, 2025
pulisher
Apr 01, 2025

Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

High Growth Tech Stocks To Watch In The US April 2025 - simplywall.st

Apr 01, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CEO sells $35.3 million in stock By Investing.com - Investing.com Philippines

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CEO sells $35.3 million in stock - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock By Investing.com - Investing.com Nigeria

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics exec sells shares worth $9.5 million By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno therapeutics director Matthew Pauls sells $424,797 in stock By Investing.com - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno therapeutics’ SVP Yen Kristen sells $4.88 million in stock - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno therapeutics director Matthew Pauls sells $424,797 in stock - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics exec sells $700,330 in stock - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CFO sells $4.88 million in stock - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics Executives and Director Sell Shares - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CCO sells shares worth $2.48m - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno therapeutics’ SVP Yen Kristen sells $4.88 million in stock By Investing.com - Investing.com UK

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CCO sells shares worth $2.48m By Investing.com - Investing.com UK

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics CFO sells $4.88 million in stock By Investing.com - Investing.com UK

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics Executives Sell Shares - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics exec sells shares worth $9.5 million - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock - Investing.com Australia

Mar 31, 2025

Soleno Therapeutics Inc (SLNO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
자본화:     |  볼륨(24시간):